CMNs develop in utero from the 5th to the 24th week of gestation due to localized genetic abnormalities with resulting over-proliferation of melanocytes.

Dysfunction of the cytokine hepatocyte growth factor, which regulates melanocyte migration and proliferation, has also been implicated in this condition.